Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Erectile Dysfunction Market Growth 2022-2028

  • LP 4940981
  • 107 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Erectile Dysfunction will have significant change from previous year. According to our (LP Information) latest study, the global Erectile Dysfunction market size is USD million in 2022 from USD 4758.1 million in 2021, with a change of % between 2021 and 2022. The global Erectile Dysfunction market size will reach USD 7793.2 million in 2028, growing at a CAGR of 7.3% over the analysis period 2022-2028.

The United States Erectile Dysfunction market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Erectile Dysfunction market, reaching US$ million by the year 2028. As for the Europe Erectile Dysfunction landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Erectile Dysfunction players cover Eli Lilly, Pfizer, Bayer, and BaiYunShan General Factory, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Erectile Dysfunction market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Sildenafil

Tadalafil

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Private Clinics

Retail Pharmacies

E-Commerce (B2B)

E-Commerce (B2C)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Eli Lilly

Pfizer

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Petros Pharmaceuticals

Seoul Pharma

Yabang Pharmacy

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Erectile Dysfunction Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Erectile Dysfunction by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Erectile Dysfunction by Country/Region, 2017, 2022 & 2028

2.2 Erectile Dysfunction Segment by Type

2.2.1 Sildenafil

2.2.2 Tadalafil

2.2.3 Others

2.3 Erectile Dysfunction Sales by Type

2.3.1 Global Erectile Dysfunction Sales Market Share by Type (2017-2022)

2.3.2 Global Erectile Dysfunction Revenue and Market Share by Type (2017-2022)

2.3.3 Global Erectile Dysfunction Sale Price by Type (2017-2022)

2.4 Erectile Dysfunction Segment by Sales Channels

2.4.1 Hospital Pharmacies

2.4.2 Private Clinics

2.4.3 Retail Pharmacies

2.4.4 E-Commerce (B2B)

2.4.5 E-Commerce (B2C)

2.5 Erectile Dysfunction Sales by Sales Channels

2.5.1 Global Erectile Dysfunction Sale Market Share by Sales Channels (2017-2022)

2.5.2 Global Erectile Dysfunction Revenue and Market Share by Sales Channels (2017-2022)

2.5.3 Global Erectile Dysfunction Sale Price by Sales Channels (2017-2022)

3 Global Erectile Dysfunction by Company

3.1 Global Erectile Dysfunction Breakdown Data by Company

3.1.1 Global Erectile Dysfunction Annual Sales by Company (2020-2022)

3.1.2 Global Erectile Dysfunction Sales Market Share by Company (2020-2022)

3.2 Global Erectile Dysfunction Annual Revenue by Company (2020-2022)

3.2.1 Global Erectile Dysfunction Revenue by Company (2020-2022)

3.2.2 Global Erectile Dysfunction Revenue Market Share by Company (2020-2022)

3.3 Global Erectile Dysfunction Sale Price by Company

3.4 Key Manufacturers Erectile Dysfunction Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Erectile Dysfunction Product Location Distribution

3.4.2 Players Erectile Dysfunction Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Erectile Dysfunction by Geographic Region

4.1 World Historic Erectile Dysfunction Market Size by Geographic Region (2017-2022)

4.1.1 Global Erectile Dysfunction Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Erectile Dysfunction Annual Revenue by Geographic Region

4.2 World Historic Erectile Dysfunction Market Size by Country/Region (2017-2022)

4.2.1 Global Erectile Dysfunction Annual Sales by Country/Region (2017-2022)

4.2.2 Global Erectile Dysfunction Annual Revenue by Country/Region

4.3 Americas Erectile Dysfunction Sales Growth

4.4 APAC Erectile Dysfunction Sales Growth

4.5 Europe Erectile Dysfunction Sales Growth

4.6 Middle East & Africa Erectile Dysfunction Sales Growth

5 Americas

5.1 Americas Erectile Dysfunction Sales by Country

5.1.1 Americas Erectile Dysfunction Sales by Country (2017-2022)

5.1.2 Americas Erectile Dysfunction Revenue by Country (2017-2022)

5.2 Americas Erectile Dysfunction Sales by Type

5.3 Americas Erectile Dysfunction Sales by Sales Channels

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Erectile Dysfunction Sales by Region

6.1.1 APAC Erectile Dysfunction Sales by Region (2017-2022)

6.1.2 APAC Erectile Dysfunction Revenue by Region (2017-2022)

6.2 APAC Erectile Dysfunction Sales by Type

6.3 APAC Erectile Dysfunction Sales by Sales Channels

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Erectile Dysfunction by Country

7.1.1 Europe Erectile Dysfunction Sales by Country (2017-2022)

7.1.2 Europe Erectile Dysfunction Revenue by Country (2017-2022)

7.2 Europe Erectile Dysfunction Sales by Type

7.3 Europe Erectile Dysfunction Sales by Sales Channels

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Erectile Dysfunction by Country

8.1.1 Middle East & Africa Erectile Dysfunction Sales by Country (2017-2022)

8.1.2 Middle East & Africa Erectile Dysfunction Revenue by Country (2017-2022)

8.2 Middle East & Africa Erectile Dysfunction Sales by Type

8.3 Middle East & Africa Erectile Dysfunction Sales by Sales Channels

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction

10.3 Manufacturing Process Analysis of Erectile Dysfunction

10.4 Industry Chain Structure of Erectile Dysfunction

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Erectile Dysfunction Distributors

11.3 Erectile Dysfunction Customer

12 World Forecast Review for Erectile Dysfunction by Geographic Region

12.1 Global Erectile Dysfunction Market Size Forecast by Region

12.1.1 Global Erectile Dysfunction Forecast by Region (2023-2028)

12.1.2 Global Erectile Dysfunction Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Erectile Dysfunction Forecast by Type

12.7 Global Erectile Dysfunction Forecast by Sales Channels

13 Key Players Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Company Information

13.1.2 Eli Lilly Erectile Dysfunction Product Offered

13.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly Main Business Overview

13.1.5 Eli Lilly Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Erectile Dysfunction Product Offered

13.2.3 Pfizer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Bayer

13.3.1 Bayer Company Information

13.3.2 Bayer Erectile Dysfunction Product Offered

13.3.3 Bayer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer Main Business Overview

13.3.5 Bayer Latest Developments

13.4 BaiYunShan General Factory

13.4.1 BaiYunShan General Factory Company Information

13.4.2 BaiYunShan General Factory Erectile Dysfunction Product Offered

13.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BaiYunShan General Factory Main Business Overview

13.4.5 BaiYunShan General Factory Latest Developments

13.5 S.K. Chemicals

13.5.1 S.K. Chemicals Company Information

13.5.2 S.K. Chemicals Erectile Dysfunction Product Offered

13.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 S.K. Chemicals Main Business Overview

13.5.5 S.K. Chemicals Latest Developments

13.6 Teva Pharma

13.6.1 Teva Pharma Company Information

13.6.2 Teva Pharma Erectile Dysfunction Product Offered

13.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Pharma Main Business Overview

13.6.5 Teva Pharma Latest Developments

13.7 Dong-A ST

13.7.1 Dong-A ST Company Information

13.7.2 Dong-A ST Erectile Dysfunction Product Offered

13.7.3 Dong-A ST Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Dong-A ST Main Business Overview

13.7.5 Dong-A ST Latest Developments

13.8 Petros Pharmaceuticals

13.8.1 Petros Pharmaceuticals Company Information

13.8.2 Petros Pharmaceuticals Erectile Dysfunction Product Offered

13.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Petros Pharmaceuticals Main Business Overview

13.8.5 Petros Pharmaceuticals Latest Developments

13.9 Seoul Pharma

13.9.1 Seoul Pharma Company Information

13.9.2 Seoul Pharma Erectile Dysfunction Product Offered

13.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Seoul Pharma Main Business Overview

13.9.5 Seoul Pharma Latest Developments

13.10 Yabang Pharmacy

13.10.1 Yabang Pharmacy Company Information

13.10.2 Yabang Pharmacy Erectile Dysfunction Product Offered

13.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Yabang Pharmacy Main Business Overview

13.10.5 Yabang Pharmacy Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Erectile Dysfunction Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Erectile Dysfunction Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Sildenafil

Table 4. Major Players of Tadalafil

Table 5. Major Players of Others

Table 6. Global Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)

Table 7. Global Erectile Dysfunction Sales Market Share by Type (2017-2022)

Table 8. Global Erectile Dysfunction Revenue by Type (2017-2022) & ($ million)

Table 9. Global Erectile Dysfunction Revenue Market Share by Type (2017-2022)

Table 10. Global Erectile Dysfunction Sale Price by Type (2017-2022) & (USD/Pill)

Table 11. Global Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)

Table 12. Global Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)

Table 13. Global Erectile Dysfunction Revenue by Sales Channels (2017-2022)

Table 14. Global Erectile Dysfunction Revenue Market Share by Sales Channels (2017-2022)

Table 15. Global Erectile Dysfunction Sale Price by Sales Channels (2017-2022) & (USD/Pill)

Table 16. Global Erectile Dysfunction Sales by Company (2020-2022) & (Million Pill)

Table 17. Global Erectile Dysfunction Sales Market Share by Company (2020-2022)

Table 18. Global Erectile Dysfunction Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Erectile Dysfunction Revenue Market Share by Company (2020-2022)

Table 20. Global Erectile Dysfunction Sale Price by Company (2020-2022) & (USD/Pill)

Table 21. Key Manufacturers Erectile Dysfunction Producing Area Distribution and Sales Area

Table 22. Players Erectile Dysfunction Products Offered

Table 23. Erectile Dysfunction Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Erectile Dysfunction Sales by Geographic Region (2017-2022) & (Million Pill)

Table 27. Global Erectile Dysfunction Sales Market Share Geographic Region (2017-2022)

Table 28. Global Erectile Dysfunction Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Erectile Dysfunction Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Erectile Dysfunction Sales by Country/Region (2017-2022) & (Million Pill)

Table 31. Global Erectile Dysfunction Sales Market Share by Country/Region (2017-2022)

Table 32. Global Erectile Dysfunction Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Erectile Dysfunction Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)

Table 35. Americas Erectile Dysfunction Sales Market Share by Country (2017-2022)

Table 36. Americas Erectile Dysfunction Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Erectile Dysfunction Revenue Market Share by Country (2017-2022)

Table 38. Americas Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)

Table 39. Americas Erectile Dysfunction Sales Market Share by Type (2017-2022)

Table 40. Americas Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)

Table 41. Americas Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)

Table 42. APAC Erectile Dysfunction Sales by Region (2017-2022) & (Million Pill)

Table 43. APAC Erectile Dysfunction Sales Market Share by Region (2017-2022)

Table 44. APAC Erectile Dysfunction Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Erectile Dysfunction Revenue Market Share by Region (2017-2022)

Table 46. APAC Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)

Table 47. APAC Erectile Dysfunction Sales Market Share by Type (2017-2022)

Table 48. APAC Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)

Table 49. APAC Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)

Table 50. Europe Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)

Table 51. Europe Erectile Dysfunction Sales Market Share by Country (2017-2022)

Table 52. Europe Erectile Dysfunction Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Erectile Dysfunction Revenue Market Share by Country (2017-2022)

Table 54. Europe Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)

Table 55. Europe Erectile Dysfunction Sales Market Share by Type (2017-2022)

Table 56. Europe Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)

Table 57. Europe Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)

Table 58. Middle East & Africa Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)

Table 59. Middle East & Africa Erectile Dysfunction Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Erectile Dysfunction Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Erectile Dysfunction Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)

Table 63. Middle East & Africa Erectile Dysfunction Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)

Table 65. Middle East & Africa Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Erectile Dysfunction

Table 67. Key Market Challenges & Risks of Erectile Dysfunction

Table 68. Key Industry Trends of Erectile Dysfunction

Table 69. Erectile Dysfunction Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Erectile Dysfunction Distributors List

Table 72. Erectile Dysfunction Customer List

Table 73. Global Erectile Dysfunction Sales Forecast by Region (2023-2028) & (Million Pill)

Table 74. Global Erectile Dysfunction Sales Market Forecast by Region

Table 75. Global Erectile Dysfunction Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Erectile Dysfunction Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Erectile Dysfunction Sales Forecast by Country (2023-2028) & (Million Pill)

Table 78. Americas Erectile Dysfunction Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Erectile Dysfunction Sales Forecast by Region (2023-2028) & (Million Pill)

Table 80. APAC Erectile Dysfunction Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Erectile Dysfunction Sales Forecast by Country (2023-2028) & (Million Pill)

Table 82. Europe Erectile Dysfunction Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Erectile Dysfunction Sales Forecast by Country (2023-2028) & (Million Pill)

Table 84. Middle East & Africa Erectile Dysfunction Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Erectile Dysfunction Sales Forecast by Type (2023-2028) & (Million Pill)

Table 86. Global Erectile Dysfunction Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Erectile Dysfunction Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Erectile Dysfunction Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Erectile Dysfunction Sales Forecast by Sales Channels (2023-2028) & (Million Pill)

Table 90. Global Erectile Dysfunction Sales Market Share Forecast by Sales Channels (2023-2028)

Table 91. Global Erectile Dysfunction Revenue Forecast by Sales Channels (2023-2028) & ($ Millions)

Table 92. Global Erectile Dysfunction Revenue Market Share Forecast by Sales Channels (2023-2028)

Table 93. Eli Lilly Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 94. Eli Lilly Erectile Dysfunction Product Offered

Table 95. Eli Lilly Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 96. Eli Lilly Main Business

Table 97. Eli Lilly Latest Developments

Table 98. Pfizer Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 99. Pfizer Erectile Dysfunction Product Offered

Table 100. Pfizer Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 101. Pfizer Main Business

Table 102. Pfizer Latest Developments

Table 103. Bayer Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 104. Bayer Erectile Dysfunction Product Offered

Table 105. Bayer Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 106. Bayer Main Business

Table 107. Bayer Latest Developments

Table 108. BaiYunShan General Factory Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 109. BaiYunShan General Factory Erectile Dysfunction Product Offered

Table 110. BaiYunShan General Factory Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 111. BaiYunShan General Factory Main Business

Table 112. BaiYunShan General Factory Latest Developments

Table 113. S.K. Chemicals Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 114. S.K. Chemicals Erectile Dysfunction Product Offered

Table 115. S.K. Chemicals Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 116. S.K. Chemicals Main Business

Table 117. S.K. Chemicals Latest Developments

Table 118. Teva Pharma Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 119. Teva Pharma Erectile Dysfunction Product Offered

Table 120. Teva Pharma Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 121. Teva Pharma Main Business

Table 122. Teva Pharma Latest Developments

Table 123. Dong-A ST Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 124. Dong-A ST Erectile Dysfunction Product Offered

Table 125. Dong-A ST Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 126. Dong-A ST Main Business

Table 127. Dong-A ST Latest Developments

Table 128. Petros Pharmaceuticals Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 129. Petros Pharmaceuticals Erectile Dysfunction Product Offered

Table 130. Petros Pharmaceuticals Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 131. Petros Pharmaceuticals Main Business

Table 132. Petros Pharmaceuticals Latest Developments

Table 133. Seoul Pharma Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 134. Seoul Pharma Erectile Dysfunction Product Offered

Table 135. Seoul Pharma Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 136. Seoul Pharma Main Business

Table 137. Seoul Pharma Latest Developments

Table 138. Yabang Pharmacy Basic Information, Erectile Dysfunction Manufacturing Base, Sales Area and Its Competitors

Table 139. Yabang Pharmacy Erectile Dysfunction Product Offered

Table 140. Yabang Pharmacy Erectile Dysfunction Sales (Million Pill), Revenue ($ Million), Price (USD/Pill) and Gross Margin (2020-2022)

Table 141. Yabang Pharmacy Main Business

Table 142. Yabang Pharmacy Latest Developments

List of Figures

Figure 1. Picture of Erectile Dysfunction

Figure 2. Erectile Dysfunction Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Erectile Dysfunction Sales Growth Rate 2017-2028 (Million Pill)

Figure 7. Global Erectile Dysfunction Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Erectile Dysfunction Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Sildenafil

Figure 10. Product Picture of Tadalafil

Figure 11. Product Picture of Others

Figure 12. Global Erectile Dysfunction Sales Market Share by Type in 2021

Figure 13. Global Erectile Dysfunction Revenue Market Share by Type (2017-2022)

Figure 14. Erectile Dysfunction Consumed in Hospital Pharmacies

Figure 15. Global Erectile Dysfunction Market: Hospital Pharmacies (2017-2022) & (Million Pill)

Figure 16. Erectile Dysfunction Consumed in Private Clinics

Figure 17. Global Erectile Dysfunction Market: Private Clinics (2017-2022) & (Million Pill)

Figure 18. Erectile Dysfunction Consumed in Retail Pharmacies

Figure 19. Global Erectile Dysfunction Market: Retail Pharmacies (2017-2022) & (Million Pill)

Figure 20. Erectile Dysfunction Consumed in E-Commerce (B2B)

Figure 21. Global Erectile Dysfunction Market: E-Commerce (B2B) (2017-2022) & (Million Pill)

Figure 22. Erectile Dysfunction Consumed in E-Commerce (B2C)

Figure 23. Global Erectile Dysfunction Market: E-Commerce (B2C) (2017-2022) & (Million Pill)

Figure 24. Global Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)

Figure 25. Global Erectile Dysfunction Revenue Market Share by Sales Channels in 2021

Figure 26. Erectile Dysfunction Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Erectile Dysfunction Revenue Market Share by Company in 2021

Figure 28. Global Erectile Dysfunction Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Erectile Dysfunction Revenue Market Share by Geographic Region in 2021

Figure 30. Global Erectile Dysfunction Sales Market Share by Region (2017-2022)

Figure 31. Global Erectile Dysfunction Revenue Market Share by Country/Region in 2021

Figure 32. Americas Erectile Dysfunction Sales 2017-2022 (Million Pill)

Figure 33. Americas Erectile Dysfunction Revenue 2017-2022 ($ Millions)

Figure 34. APAC Erectile Dysfunction Sales 2017-2022 (Million Pill)

Figure 35. APAC Erectile Dysfunction Revenue 2017-2022 ($ Millions)

Figure 36. Europe Erectile Dysfunction Sales 2017-2022 (Million Pill)

Figure 37. Europe Erectile Dysfunction Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Erectile Dysfunction Sales 2017-2022 (Million Pill)

Figure 39. Middle East & Africa Erectile Dysfunction Revenue 2017-2022 ($ Millions)

Figure 40. Americas Erectile Dysfunction Sales Market Share by Country in 2021

Figure 41. Americas Erectile Dysfunction Revenue Market Share by Country in 2021

Figure 42. United States Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Erectile Dysfunction Sales Market Share by Region in 2021

Figure 47. APAC Erectile Dysfunction Revenue Market Share by Regions in 2021

Figure 48. China Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Erectile Dysfunction Sales Market Share by Country in 2021

Figure 55. Europe Erectile Dysfunction Revenue Market Share by Country in 2021

Figure 56. Germany Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Erectile Dysfunction Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Erectile Dysfunction Revenue Market Share by Country in 2021

Figure 63. Egypt Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Erectile Dysfunction Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Erectile Dysfunction in 2021

Figure 69. Manufacturing Process Analysis of Erectile Dysfunction

Figure 70. Industry Chain Structure of Erectile Dysfunction

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390